Das Credo VitaPCR™ System hat die CAP-Eignungsprüfung bestanden
Credo Diagnostics Biomedical Pte. Ltd. to uphold quality and demonstrate product performance as well as compare it with competing brands in the market. Our VitaPCR™ system has successfully passed the CAP (College of American Pathologists) proficiency testing. Our team participated in the CAP ID3-B 2024 Nucleic Acid Amplification, Respiratory Limited panel which included tests for Influenza A, […]
